These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12097462)

  • 1. Invited commentary: one step forward.
    Lastoria S; Piccolo S; Muto P
    J Nucl Med; 2002 Jul; 43(7):916-7. PubMed ID: 12097462
    [No Abstract]   [Full Text] [Related]  

  • 2. Tc-99m sestamibi exam finds niche in breast Dx.
    Chen EM; Khalkhali I; Cutrone JA; Diggles LE; Mishkin F
    Diagn Imaging (San Franc); 1997 Aug; 19(8):61-5. PubMed ID: 10169379
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of patient positioning in scintimammography.
    Mirzaei S; Knoll P; Köhn H; Lipp RW; Zajicek SM
    Eur J Nucl Med; 2001 Sep; 28(9):1437-8. PubMed ID: 11585308
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast-specific gamma imaging for detection of breast cancer.
    Riordan W
    Radiology; 2009 Apr; 251(1):306; author reply 306. PubMed ID: 19332861
    [No Abstract]   [Full Text] [Related]  

  • 5. High-resolution scintimammography: a pilot study.
    Brem RF; Schoonjans JM; Kieper DA; Majewski S; Goodman S; Civelek C
    J Nucl Med; 2002 Jul; 43(7):909-15. PubMed ID: 12097461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast-specific gamma imaging (BSGI), molecular breast imaging (MBI), or scintimammography with breast-specific gamma camera.
    BlueCross BlueShield Association
    Technol Eval Cent Assess Program Exec Summ; 2013 Jun; 28(2):1-4. PubMed ID: 23865107
    [No Abstract]   [Full Text] [Related]  

  • 7. Procedure guideline for breast scintigraphy. Society of Nuclear Medicine.
    Khalkhali I; Diggles LE; Taillefer R; Vandestreek PR; Peller PJ; Abdel-Nabi HH
    J Nucl Med; 1999 Jul; 40(7):1233-5. PubMed ID: 10405150
    [No Abstract]   [Full Text] [Related]  

  • 8. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
    Mirzaei S; Knoll P; Lipp RW; Köhn H
    J Nucl Med; 2000 Feb; 41(2):390-1. PubMed ID: 10688127
    [No Abstract]   [Full Text] [Related]  

  • 9. Scintimammography in breast cancer diagnosis.
    Newman J
    Radiol Technol; 1998; 70(2):153-68; quiz 169-72. PubMed ID: 9839329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scintimammography: the new role of technetium-99m Sestamibi imaging for the diagnosis of breast carcinoma.
    Khalkhali I; Iraniha S; Diggles LE; Cutrone JA; Mishkin FS
    Q J Nucl Med; 1997 Sep; 41(3):231-8. PubMed ID: 9274131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
    Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breast-specific gamma imaging in breast cancer].
    van Loevezijn AA; van Breda Vriesman AC; Neijenhuis PA; Pereira Arias-Bouda LM
    Ned Tijdschr Geneeskd; 2016; 160():A9610. PubMed ID: 26786798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.
    Chen S; Liu W; Mao Y; Zhu W; Yao Z; Sun X; Xiu Y; Yin Y; Chen J
    Chin Med J (Engl); 2000 May; 113(5):400-3. PubMed ID: 11776092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of craniocaudal thallium-201 and technetium-99m-sestamibi mammoscintigraphy.
    Maurer AH; Caroline DF; Jadali FJ; Manzone TA; Maier WP; Au FC; Schnall SF
    J Nucl Med; 1995 Sep; 36(9):1696-700. PubMed ID: 7658233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
    Delpassand ES; Jackson EF
    Radiology; 1997 Oct; 205(1):283-4; author reply 285-6. PubMed ID: 9315002
    [No Abstract]   [Full Text] [Related]  

  • 16. Technetium-99m sestamibi in the diagnosis of breast cancer. The Mayagüez Medical Center experience.
    Farías-Jimenez J; Rivera A; Carlo VM
    Bol Asoc Med P R; 2001; 93(1-12):9-11. PubMed ID: 12755069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific effects on uptake of 99mTc-sestamibi by breast lesions: a targeted analysis of false scintigraphic diagnoses.
    Tiling R; Stephan K; Sommer H; Shabani N; Linke R; Hahn K
    J Nucl Med; 2004 Nov; 45(11):1822-8. PubMed ID: 15534050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.
    Villanueva-Meyer J; Leonard MH; Briscoe E; Cesani F; Ali SA; Rhoden S; Hove M; Cowan D
    J Nucl Med; 1996 Jun; 37(6):926-30. PubMed ID: 8683313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of patient positioning in scintimammography.
    Mirzaei S
    Eur J Nucl Med; 2001 Jul; 28(7):941-2. PubMed ID: 11504096
    [No Abstract]   [Full Text] [Related]  

  • 20. A perspective on decision analysis modeling as it relates to sestamibi imaging of nonpalpable breast abnormalities.
    Waxman AD
    J Nucl Med; 1997 Nov; 38(11):1778-80. PubMed ID: 9374353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.